Literature DB >> 14504409

The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.

Eric S Martin1, Rossano Cesari, Francesca Pentimalli, Kristine Yoder, Richard Fishel, Andrew L Himelstein, S Eric Martin, Andrew K Godwin, Massimo Negrini, Carlo M Croce.   

Abstract

Frequent allelic loss at human chromosome 11q23-q24 occurs in a wide variety of cancers, suggesting that this region may harbor a tumor suppressor gene. By constructing a physical map of the LOH11CR2 minimal region of loss on 11q23-q24 associated with lung and breast carcinomas, we were able to clone a hereditary translocation, t(11;12)(q23;q24), in a patient with early-onset breast cancer and family history of cancer. The breakpoint was found within 6 kb of the BCSC-1 candidate tumor suppressor gene located in the LOH11CR2 region whereas additional loss of heterozygosity (LOH) analysis in breast and ovarian tumors, including that of the patient with the t(11;12)(q23;q24), implicated the BCSC-1 locus as the primary target of deletion. Northern analysis of the BCSC-1 mRNA revealed a lack of expression in 33 of 41 (80%) tumor cell lines, and its ectopic expression led to the suppression of colony formation in vitro and tumorigenicity in vivo. These data suggest that BCSC-1 may exert a tumor suppressor activity and is a likely target of the LOH observed on 11q23-q24 in cancer.

Entities:  

Mesh:

Year:  2003        PMID: 14504409      PMCID: PMC208790          DOI: 10.1073/pnas.1934602100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species.

Authors:  K Savitsky; S Sfez; D A Tagle; Y Ziv; A Sartiel; F S Collins; Y Shiloh; G Rotman
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

2.  Involvement of the ALL-1 gene in a solid tumor.

Authors:  R Baffa; M Negrini; S A Schichman; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

3.  Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.

Authors:  J Koreth; P B Bethwaite; J O McGee
Journal:  J Pathol       Date:  1995-05       Impact factor: 7.996

4.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.

Authors:  M Negrini; D Rasio; G M Hampton; S Sabbioni; S Rattan; S L Carter; A L Rosenberg; G F Schwartz; Y Shiloh; W K Cavenee
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

5.  Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions.

Authors:  D Rasio; M Negrini; G Manenti; T A Dragani; C M Croce
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

6.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

7.  Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.

Authors:  M Davis; A Hitchcock; W D Foulkes; I G Campbell
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

8.  Loss of heterozygosity at 11q22-q23 in breast cancer.

Authors:  S L Carter; M Negrini; R Baffa; D R Gillum; A L Rosenberg; G F Schwartz; C M Croce
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

9.  The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation.

Authors:  I Vorechovský; D Rasio; L Luo; C Monaco; L Hammarström; A D Webster; J Zaloudik; G Barbanti-Brodani; M James; G Russo
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

10.  Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

Authors:  H Gabra; L Taylor; B B Cohen; A Lessels; D M Eccles; R C Leonard; J F Smyth; C M Steel
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more
  16 in total

1.  Pioneering the Xenopus oocyte and egg extract system.

Authors:  James L Maller
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

2.  Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.

Authors:  Satyabrata Sinha; Ratnesh K Singh; Nilanjana Bhattacharya; Nupur Mukherjee; Susmita Ghosh; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

3.  Frequent loss of the BLID gene in early-onset breast cancer.

Authors:  L R Cavalli; A-M Noone; K H Makambi; J D Rone; U N Kasid; B R Haddad
Journal:  Cytogenet Genome Res       Date:  2011-08-12       Impact factor: 1.636

4.  11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation.

Authors:  Nga Du; Pamela M Baker; To Uyen Do; Christine Bien; Carol M Bier-Laning; Sheetal Singh; Shyh-Jen Shih; Manual O Diaz; Andrew T Vaughan
Journal:  Genes Chromosomes Cancer       Date:  2010-09       Impact factor: 5.006

5.  Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma.

Authors:  Ratnesh Kumar Singh; Santanu Dasgupta; Nilanjana Bhattacharya; Neelanjana Chunder; Ranjit Mondal; Anup Roy; Syamsundar Mandal; Susanta Roychowdhury; Chinmay Kumar Panda
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-15       Impact factor: 4.553

6.  Comprehensive analysis of MHC class I genes from the U-, S-, and Z-lineages in Atlantic salmon.

Authors:  Morten F Lukacs; Håvard Harstad; Hege G Bakke; Marianne Beetz-Sargent; Linda McKinnel; Krzysztof P Lubieniecki; Ben F Koop; Unni Grimholt
Journal:  BMC Genomics       Date:  2010-03-05       Impact factor: 3.969

7.  LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer.

Authors:  D C T Ong; Y M Ho; C Rudduck; K Chin; W-L Kuo; D K H Lie; C L M Chua; P H Tan; K W Eu; F Seow-Choen; C Y Wong; G S Hong; J W Gray; A S G Lee
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

8.  High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients.

Authors:  M Wang; X Zhu; Z Sha; N Li; D Li; L Chen
Journal:  Br J Cancer       Date:  2015-02-10       Impact factor: 7.640

9.  MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b.

Authors:  Yiyi Li; Yilan Chao; Yuan Fang; Jian Wang; Min Wang; Hong Zhang; Min Ying; Xiaoxia Zhu; Haofei Wang
Journal:  J Exp Clin Cancer Res       Date:  2013-05-29

10.  Inbreeding and homozygosity in breast cancer survival.

Authors:  Hauke Thomsen; Miguel Inacio da Silva Filho; Andrea Woltmann; Robert Johansson; Jorunn E Eyfjörd; Ute Hamann; Jonas Manjer; Kerstin Enquist-Olsson; Roger Henriksson; Stefan Herms; Per Hoffmann; Bowang Chen; Stefanie Huhn; Kari Hemminki; Per Lenner; Asta Försti
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.